The Food and Drug Administration (FDA) has conditionally approved the antiviral drug remdesivir to treat people with severe COVID-19, the Central Epidemic Command Center (CECC) said yesterday.
At the CECC’s daily news conference in Taipei, Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the center, said that no new cases have been confirmed, while 421 people have been released from isolation after contracting the novel coronavirus.
“Taiwan remains the same — with no new domestic cases reported in 48 consecutive days,” Chen said. “However, the COVID-19 situation globally is still serious and almost 6 million cases have been confirmed, so we have to be extra careful about border controls.”
Photo: CNA
After a specialist meeting on Friday, the FDA approved remdesivir to treat people with severe COVID-19, Chen said.
FDA Director-General Wu Shou-mei (吳秀梅) said that to respond to the pandemic, Taiwan needs to prepare treatments, so the administration reached out to pharmaceutical companies.
Gilead Sciences Inc, which produces the experimental antiviral drug under the brand name Veklury, on Monday submitted documents to have the drug approved, and the FDA and the Center for Drug Evaluation immediately launched a review, Wu said.
Photo: CNA
The review was completed by Thursday and with the meeting on Friday, the agencies decided that based on Article 48 of the Pharmaceutical Affairs Act (藥事法), conditional approval would be granted to import Veklury, she said.
The drug can be used to treat severe cases in adults and children, with treatment limited to a maximum of 10 days, she said.
Gilead must enforce a risk management plan and the results of new clinical trials must be immediately sent to the FDA for review, while technical data must be collated within a year, Wu said.
Adult patients are to have 200mg of the drug injected on the first day and receive a 100mg injection once per day from the second day, while children are to be given the same doses if they weigh at least 40kg, she said, adding that dosages would be adjusted according to body weight for children who weigh less than 40kg.
“As many clinical trials are still ongoing, it [remdesivir] is so far one of the most promising drugs we have observed, but the drug approval was granted quickly in response to the emergency need in Taiwan,” Wu said.
The US Food and Drug Administration on May 1 gave the drug emergency use authorization for people hospitalized with severe COVID-19, while Japan on May 7 was the first nation to grant it regulatory approval.
Taiwan is the second nation in the world to have approved the drug.
CECC advisory specialist panel convener Chang Shan-chwen (張上淳) said that although evidence might not yet be sufficient, information on the drug’s effects has been positive, so most specialists support importing the drug to prepare the health system for the possibility of another outbreak.
The drug would only be administered with the informed consent of the patient, and their kidney and liver functions would be monitored to check for adverse reactions, Chang said.
Remdesivir was developed to treat Ebola, but clinical trials showed that it was not effective enough, Wu said.
However, it improved symptoms in severe COVID-19 cases in clinical trials, in which 11 Taiwanese participated, she said.
After the conditional approval is officially granted next week, the FDA plans to order 1,000 doses, which are expected to arrive in Taiwan by late July at the earliest, she said.
RETHINK? The defense ministry and Navy Command Headquarters could take over the indigenous submarine project and change its production timeline, a source said Admiral Huang Shu-kuang’s (黃曙光) resignation as head of the Indigenous Submarine Program and as a member of the National Security Council could affect the production of submarines, a source said yesterday. Huang in a statement last night said he had decided to resign due to national security concerns while expressing the hope that it would put a stop to political wrangling that only undermines the advancement of the nation’s defense capabilities. Taiwan People’s Party Legislator Vivian Huang (黃珊珊) yesterday said that the admiral, her older brother, felt it was time for him to step down and that he had completed what he
Taiwan has experienced its most significant improvement in the QS World University Rankings by Subject, data provided on Sunday by international higher education analyst Quacquarelli Symonds (QS) showed. Compared with last year’s edition of the rankings, which measure academic excellence and influence, Taiwanese universities made great improvements in the H Index metric, which evaluates research productivity and its impact, with a notable 30 percent increase overall, QS said. Taiwanese universities also made notable progress in the Citations per Paper metric, which measures the impact of research, achieving a 13 percent increase. Taiwanese universities gained 10 percent in Academic Reputation, but declined 18 percent
CHINA REACTS: The patrol and reconnaissance plane ‘transited the Taiwan Strait in international airspace,’ the 7th Fleet said, while Taipei said it saw nothing unusual The US 7th Fleet yesterday said that a US Navy P-8A Poseidon flew through the Taiwan Strait, a day after US and Chinese defense heads held their first talks since November 2022 in an effort to reduce regional tensions. The patrol and reconnaissance plane “transited the Taiwan Strait in international airspace,” the 7th Fleet said in a news release. “By operating within the Taiwan Strait in accordance with international law, the United States upholds the navigational rights and freedoms of all nations.” In a separate statement, the Ministry of National Defense said that it monitored nearby waters and airspace as the aircraft
UNDER DISCUSSION: The combatant command would integrate fast attack boat and anti-ship missile groups to defend waters closest to the coastline, a source said The military could establish a new combatant command as early as 2026, which would be tasked with defending Taiwan’s territorial waters 24 nautical miles (44.4km) from the nation’s coastline, a source familiar with the matter said yesterday. The new command, which would fall under the Naval Command Headquarters, would be led by a vice admiral and integrate existing fast attack boat and anti-ship missile groups, along with the Naval Maritime Surveillance and Reconnaissance Command, said the source, who asked to remain anonymous. It could be launched by 2026, but details are being discussed and no final timetable has been announced, the source